版本:
中国

BRIEF-Concert Pharmaceuticals initiates CTP-543 phase 2 trial in alopecia areata

May 2 Concert Pharmaceuticals Inc:

* Concert Pharmaceuticals initiates ctp-543 phase 2 trial in alopecia areata

* Concert Pharmaceuticals Inc - company expects to report topline data in Q1 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐